Crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumours with and without anaplastic lymphoma kinase gene alterations (European Organisation for Research and Treatment of Cancer 90101 CREATE): a multicentre, single-drug, prospective, non-randomised phase 2 trial
2018 ◽
Vol 6
(6)
◽
pp. 431-441
◽
Patrick Schöffski
◽
Jozef Sufliarsky
◽
Hans Gelderblom
◽
Jean-Yves Blay
◽
Sandra J Strauss
◽
...
2013 ◽
Vol 67
(1)
◽
pp. 33-39
◽
Jae Seok Lee
◽
Sun Min Lim
◽
Sun Young Rha
◽
Jae Kyung Roh
◽
Yong Jin Cho
◽
...
2016 ◽
Vol 17
(1)
◽
pp. 85-90
◽
Vignesh Narayanan
◽
M. Justin Honce
◽
Sanjana Mehrotra
◽
D. Ross Camidge
2014 ◽
Vol 53
(23)
◽
pp. 2711-2715
◽
Naoki Watanabe
◽
Tomoya Ishii
◽
Takayuki Takahama
◽
Akira Tadokoro
◽
Nobuhiro Kanaji
◽
...
2020 ◽
Vol Volume 13
◽
pp. 6927-6935
De-Ning Ma
◽
Xin-Yi Gao
◽
Yi-Bo Dan
◽
An-Ni Zhang
◽
Wei-Jun Wang
◽
...
2010 ◽
Vol 46
(13)
◽
pp. 2357-2368
◽
Fergal C. Kelleher
◽
Ray McDermott
2017 ◽
Vol 112
◽
pp. 1-9
◽
Zili Wang
◽
Haitao Yang
◽
Shuimei Luo
◽
Bo Liu
◽
Nianhai Zhang
◽
...
2012 ◽
Vol 7
(1)
◽
pp. 5-7
◽
Benjamin Solomon
◽
Alice T. Shaw
2018 ◽
Vol 121
◽
pp. e3-e4
◽
Kazuki Okubo
◽
Akinori Sato
◽
Keitaro Nakamoto
◽
Yuki Hatanaka
◽
Makoto Isono
◽
...
2016 ◽
Vol 33
(3)
◽
pp. 154
◽
Shengle Zhang
◽
Weisheng Xu
◽
KamalK Khurana
◽
Jamie Tull
◽
Charlene Maciak
Close
Export Citation Format
Close
Share Document
Close